Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Khansa Osama Abdelkarim Aloub, Noha Ibrahim Ahmed Eltahirm, Elnour Mohammed Elagib, Mohammed Elmujtba Adam Essa & Mustafa Mohammed Ali Hussein. (2022) Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study. Open Access Rheumatology: Research and Reviews 14, pages 301-308.
Read now
Read now
Lukmanee Tradtrantip, Nithi Asavapanumas & Alan S. Verkman. (2020) Emerging therapeutic targets for neuromyelitis optica spectrum disorder. Expert Opinion on Therapeutic Targets 24:3, pages 219-229.
Read now
Read now
C-R Wang, M-F Liu, C-T Weng, W-C Lin, W-T Li & H-W Tsai. (2018) Systemic lupus erythematosus-associated diffuse alveolar haemorrhage: a single-centre experience in Han Chinese patients. Scandinavian Journal of Rheumatology 47:5, pages 392-399.
Read now
Read now
Massimo Radin, Irene Cecchi, Karen Schreiber, Simone Baldovino, Daniela Rossi, Elisa Menegatti, Dario Roccatello & Savino Sciascia. (2017) Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus. Expert Opinion on Orphan Drugs 5:1, pages 55-69.
Read now
Read now
Jorge Medina-Rosas, Hanan Al-Rayes, Ahmed T. Moustafa & Zahi Touma. (2016) Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials. Expert Opinion on Biological Therapy 16:10, pages 1225-1238.
Read now
Read now
Huza Zhang, William Chambers, Savino Sciascia & Maria J. Cuadrado. (2016) Emerging therapies in systemic lupus erythematous: from clinical trial to the real life. Expert Review of Clinical Pharmacology 9:5, pages 681-694.
Read now
Read now
Domenico Santoro, Vincenzo Pellicanò, Luca Visconti, Gianluca Trifirò, Valeria Cernaro & Michele Buemi. (2015) Monoclonal antibodies for renal diseases: current concepts and ongoing treatments. Expert Opinion on Biological Therapy 15:8, pages 1119-1143.
Read now
Read now
Thomas G Forsthuber & Timothy RDJ Radstake. (2015) Expert Review of Clinical Immunology 10-year anniversary issue. Expert Review of Clinical Immunology 11:1, pages 1-3.
Read now
Read now
Articles from other publishers (31)
Chrong-Reen Wang & Hung-Wen Tsai. (2023) Seronegative spondyloarthropathy-associated inflammatory bowel disease. World Journal of Gastroenterology 29:3, pages 450-468.
Crossref
Crossref
Selma Cecilia Scheffler Mendoza, Francisco Eduardo Rivas-Larrauri & Ana Luisa Rodríguez-Lozano. 2022. Common Pediatric Diseases: an Updated Review. Common Pediatric Diseases: an Updated Review
324
374
.
Shinichi Matsuda, Takumi Ohtomo, Shiho Tomizawa, Yuki Miyano, Miwako Mogi, Hiroshi Kuriki, Terumi Nakayama & Shinichi Watanabe. (2021) Incorporating Unstructured Patient Narratives and Health Insurance Claims Data in Pharmacovigilance: Natural Language Processing Analysis of Patient-Generated Texts About Systemic Lupus Erythematosus. JMIR Public Health and Surveillance 7:6, pages e29238.
Crossref
Crossref
Siegfried Kohler, Stefanie Märschenz, Ulrike Grittner, Tobias Alexander, Falk Hiepe & Andreas Meisel. (2019) Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial. BMJ Open 9:1, pages e024523.
Crossref
Crossref
Laura Durcan & Michelle Petri. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes
532
542
.
E Peterknecht, M P Keasey & M W Beresford. (2018) The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review. Lupus 27:13, pages 2135-2145.
Crossref
Crossref
D. Clemente Garulo, L. León Mateos & J.C. López Robledillo. (2018) Enfermedades reumáticas en la adolescencia. Artritis idiopática juvenil. Conectivopatías. Medicine - Programa de Formación Médica Continuada Acreditado 12:61, pages 3588-3600.
Crossref
Crossref
Yoshiya Tanaka, Akiko Mizukami, Akihiro Kobayashi, Chie Ito & Taizo Matsuki. (2018) Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study. International Journal of Rheumatic Diseases 21:8, pages 1609-1618.
Crossref
Crossref
Virginie Jadot, Jean-Marie Krzesinski, Christian Von Frenckell, Christophe Bovy & Antoine Bouquegneau. (2018) La néphropathie lupique : les nouvelles perspectives de traitement. Néphrologie & Thérapeutique 14:1, pages 1-12.
Crossref
Crossref
Savino Sciascia, Massimo Radin, Dario Roccatello, Giovanni Sanna & Maria Laura Bertolaccini. (2018) Recent advances in the management of systemic lupus erythematosus. F1000Research 7, pages 970.
Crossref
Crossref
Chrong-Reen Wang, Chia-Tse Weng, Chung-Ta Lee, Kuo-Yuan Huang, Sheng-Min Hsu & Ming-Fei Liu. (2017) Rare occurrence of inflammatory bowel disease in a cohort of Han Chinese ankylosing spondylitis patients- a single institute study. Scientific Reports 7:1.
Crossref
Crossref
Tatyana A. Shamliyan & Paula Dospinescu. (2017) Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis. Clinical Therapeutics 39:7, pages 1479-1506.e45.
Crossref
Crossref
Vera Golder, Molla Huq, Kate Franklyn, Alicia Calderone, Aisha Lateef, Chak Sing Lau, Alfred Lok Hang Lee, Sandra Teresa V. Navarra, Timothy Godfrey, Shereen Oon, Alberta Yik Bun Hoi, Eric Francis Morand & Mandana Nikpour. (2017) Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study. Seminars in Arthritis and Rheumatism 46:6, pages 798-803.
Crossref
Crossref
Vera Golder & Alberta Hoi. (2017) Systemic lupus erythematosus: an update. Medical Journal of Australia 206:5, pages 215-220.
Crossref
Crossref
Vera Golder, Eric F. Morand & Alberta Y. Hoi. (2017) Quality of Care for Systemic Lupus Erythematosus: Mind the Knowledge Gap. The Journal of Rheumatology 44:3, pages 271-278.
Crossref
Crossref
S Sciascia, M Radin, J Yazdany, RA Levy, D Roccatello, M Dall'Era & MJ Cuadrado. (2017) Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review. Autoimmunity Reviews 16:3, pages 287-293.
Crossref
Crossref
Tian Yu, Elena Y. Enioutina, Hermine I. Brunner, Alexander A. Vinks & Catherine M. Sherwin. (2016) Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus. Clinical Pharmacokinetics 56:2, pages 107-125.
Crossref
Crossref
Vera Golder, Rangi Kandane-Rathnayake, Alberta Yik-Bun Hoi, Molla Huq, Worawit Louthrenoo, Yuan An, Zhan Guo Li, Shue Fen Luo, Sargunan Sockalingam, Chak Sing Lau, Alfred Lok Lee, Mo Yin Mok, Aisha Lateef, Kate Franklyn, Susan Morton, Sandra Teresa V. Navarra, Leonid Zamora, Yeong-Jian Wu, Laniyati Hamijoyo, Madelynn Chan, Sean O’Neill, Fiona Goldblatt, Eric Francis Morand & Mandana Nikpour. (2016) Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Andreas Schwarting, Johann O. Schroeder, Tobias Alexander, Marc Schmalzing, Christoph Fiehn, Christof Specker, Alessandra Perna, Constanze Cholmakow-Bodechtel, Volker B. Koscielny & Heike Carnarius. (2016) First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study. Rheumatology and Therapy 3:2, pages 271-290.
Crossref
Crossref
M. Schneider. (2016) Pitfalls in lupus. Autoimmunity Reviews 15:11, pages 1089-1093.
Crossref
Crossref
Chrong-Reen Wang & Ming-Fei Liu. (2016) Rituximab usage in systemic lupus erythematosus-associated antiphospholipid syndrome: A single-center experience. Seminars in Arthritis and Rheumatism 46:1, pages 102-108.
Crossref
Crossref
K Thorarinsdottir, A Camponeschi, N Cavallini, O Grimsholm, L Jacobsson, I Gjertsson & I-L Mårtensson. (2016) CD21–/low B cells in human blood are memory cells. Clinical and Experimental Immunology 185:2, pages 252-262.
Crossref
Crossref
Vladimir Tesar. (2016) Moderator's view: Cyclophosphamide in lupus nephritis. Nephrology Dialysis Transplantation 31:7, pages 1058-1061.
Crossref
Crossref
Lin-Ying Chen, Julia Y S Tsang, Yun-Bi Ni, Siu-Ki Chan, Kui-Fat Chan, Sheng Zhang & Gary M Tse. (2016) Lymphocyte subsets contribute to the degree of lobulitis and ductitis in sclerosing lymphocytic lobulitis of the breast. Journal of Clinical Pathology 69:6, pages 527-532.
Crossref
Crossref
José Mario Sabio. (2016) Lupus eritematoso sistémico a día de hoy. Medicina Clínica 146:4, pages 160-162.
Crossref
Crossref
José Mario Sabio. (2016) Systemic lupus erythematosus today. Medicina Clínica (English Edition) 146:4, pages 160-162.
Crossref
Crossref
Barbara Dema & Nicolas Charles. (2016) Autoantibodies in SLE: Specificities, Isotypes and Receptors. Antibodies 5:1, pages 2.
Crossref
Crossref
Liuye Huang, Yuan Yang, Yu Kuang, Dapeng Wei, Wanyi Li, Qin Yin, Juan Pang & Zhongwei Zhang. (2016) The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation. Journal of Immunology Research 2016, pages 1-9.
Crossref
Crossref
Harry Alexopoulos, Angie Biba & Marinos C. Dalakas. (2015) Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials. Neurotherapeutics 13:1, pages 20-33.
Crossref
Crossref
Thomas Dörner, Anthony Shock, David M. Goldenberg & Peter E. Lipsky. (2015) The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. Autoimmunity Reviews 14:12, pages 1079-1086.
Crossref
Crossref
Stanley C. Jordan, Jua Choi & Ashley Vo. (2015) Kidney transplantation in highly sensitized patients. British Medical Bulletin 114:1, pages 113-125.
Crossref
Crossref